family slam health trust after pensioner's 'undignified' death.

.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..
. why novartis� landmark cancer drug approval is great news for bluebird.
fda commissioner: it�s not a secret, sir. many experts know about it..